NCT04999761 2024-09-25AB122 Platform StudyTaiho Pharmaceutical Co., Ltd.Phase 1 Recruiting917 enrolled
NCT02376699 2023-05-01Safety Study of SEA-CD40 in Cancer PatientsSeagen Inc.Phase 1 Terminated159 enrolled
NCT00620295 2017-11-29Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid TumorsMasonic Cancer Center, University of MinnesotaPhase 1 Completed17 enrolled
NCT01325558 2016-07-15A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid TumorsAltor BioSciencePhase 1 Completed30 enrolled
NCT00176241 2015-06-08Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck CancerUniversity of KentuckyPhase 1 Terminated7 enrolled
NCT00004097 2013-09-20Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck CancerNational Cancer Institute (NCI)Phase 1 Unknown
NCT00014456 2013-08-28Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid TumorsDartmouth-Hitchcock Medical CenterPhase 1 Completed35 enrolled